Some scholars have considered NfL as a disease activity indicator for multiple sclerosis, Parkinson’s disease, and other disorders; however, few reports exist on the application of this index for the efficacy monitoring of alcohol-related brain injury, which is an innovation of this study. This evidence concerns the gene NEFL and multiple sclerosis.